<< Research shows Caspase-1 protein plays a key role in the process of inflammation and colon cancer | CIGNA International expands Global Access Health Network >>
Read in | English | Nederlands | עִבְרִית

Micromet announces the closing of previously announced underwritten public offering

Published on March 18, 2010 at 1:44 AM · No Comments

Micromet, Inc. (Nasdaq: MITI) announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised in full their option to purchase an additional 1.5 million shares of common stock. As a result, Micromet sold a total of 11.5 million shares of its common stock at a public offering price of $7.00 per share.

The Company received net proceeds from the offering of approximately $75.3 million, after deducting the underwriting discount and estimated offering expenses.  The Company plans to use the net proceeds from the financing primarily for general corporate purposes, which may include research and development, capital expenditures, working capital and general and administrative expenses.

SOURCE Micromet, Inc.

Posted in:

Tags: , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading